An increasing number of innovative firms have been chosen for the third edition of the LeadiNNg to Scale-Up program, which started on January 23, 2024. Among them, 5 are part of the Biopôle community: Aspivix, Limula, Genknowme, Roumai medical and Volumina. A great turnout that we can only be proud of!
IMD and Innovaud have been supporting startups for many years through initiatives such as the IMD Startup Competition and Scale Up Vaud programs. In 2022, the longtime partner institutions decided to launch the LeadiNNg to Scale Up program to fill a gap in Switzerland’s innovation support ecosystem.
“After getting their business off the ground and completing their all-important first funding round, tech startup founders need targeted support to kick-start the scale-up process, recruit talent, and get their company ready to grow fast,” explained Patrick Barbey, Innovaud Director.
Thanks to targeted support and courses by IMD professors and serial entrepreneurs, IMD and Innovaud are aiming to propel startups to scale-ups with even better support. Since the first edition, already 26 companies have gone through the program. The program has brought numerous benefits to entrepreneurs in order to meet these challenges as explains Frank Bonnet, co-founder and CEO of Bionomous: “It’s a great way to avoid key mistakes and have better chances to have great success in your company”.
LeadiNNg to Scale-Up 2024
The 3rd cohort of LeadiNNG to Scale-up was launched on 23 January 2024. 16 companies represented by their CEOs and co-founders gathered for the first session on the IMD campus.